Reach Us +447482877761
Metabolomics and its Value in Today's Era | OMICS International | Abstract
ISSN: 0974-7230

Journal of Computer Science & Systems Biology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Metabolomics and its Value in Today's Era

Kadambini Tripathy1*, Tushar Nanda1, Saraswathi Chinnapatlola2 and O.V. Sudharani2

1Department of Bioscience and Biotechnology, Fakir Mohan University, Orissa-756020, India

2Centre for Biotechnology, IST, Jawaharlal Nehru Technological University Hyderabad-500042, India

*Corresponding Author:
Kadambini Tripathy
Department of Bioscience & Biotechnology
Fakir Mohan University, Orissa-756020, India
E-mail: [email protected]

Received date: June 15, 2011; Accepted date: July 20, 2011; Published date: July 23, 2011

Citation: Tripathy K, Nanda T, Chinnapatlola S, Sudharani OV (2011) Metabolomics and its Value in Today’s Era. J Comput Sci Syst Biol S13:001. doi:10.4172/jcsb.S13-001

Copyright: © 2011 Tripathy K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Metabolomics is the newly emerging field of ‘omics’ research.Its Comprehensive and simultaneous systematic determination of metabolite levels in the metabolome and their changes over time.This review outlines how metabolomics is emerging in today’s life. It presents metabolomics methodology and focuses on the current and potential applications of metabolomics in different diseases with particular attention to its use as a biomarker in diagnosis, prognosis, and therapeutic evaluation. We think this review will appeal to both translational researchers and clinicians as it reviews up-to-date evidence on the utility of metabolomics, an often poorly understood topic. The report also highlights the use of metabolomics in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics.


Recommended Conferences

16th World Congress on Structural Biology

Amsterdam, Netherlands
Share This Page